Moxaverine Hydrochloride

盐酸莫沙维林

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameMoxaverine Hydrochloride
Drug Alias Name盐酸去甲氧罂粟碱moxaverinummoxaverina1-苄基-3-乙基-6,7-二甲氧基异喹啉盐酸盐Paverine +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action3',5'-cyclic phosphodiesterase inhibitors
Targets3',5'-cyclic phosphodiesterase
Therapy Area/IndicationsIschemiaCardiovascular DiseasesMacular Degeneration +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustria
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMedical University Of Vienna
Active IndicationsCardiovascular DiseasesMuscle Spasticity
Inactive IndicationsIschemiaMacular DegenerationRetinal Diseases +[4] 

Other Information

ATC CodeA03AD30
Related LinksWikipediaKEGG